Lantern Pharma (LTRN)

• Market cap: $45.8M
• 1 day: -5.28%
• 5 days: 1.99%
• 1 month: 66.2%
• 3 months: 31.5%
• 6 months: -4.27%
• Year to date: 15.43%
• 1 year: 4.66%
• 5 years: -77.63%
• 10 years: -75.99%
• Sector: Healthcare
• Industry: Biotechnology

About: Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.

Employees: 16